Adoption of Nano-Drug Delivery Systems Presents Opportunities

DUBLIN, October 11, 2022 /PRNewswire/ — The “Global Pharmaceutical Drug Delivery Market Report 2022” report has been added to from ResearchAndMarkets.com offer.

The global pharmaceutical drug delivery market is expected to grow from $1510.17 billion in 2021 for $1591.81 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The Pharmaceutical Drug Delivery Market is Expected to Grow to Reach $1920.96 billion in 2026 at a CAGR of 4.8%.

North America was the largest region in the pharmaceutical drug delivery market in 2021. North America is expected to be the fastest growing region during the forecast period. Regions covered in this Pharmaceutical Drug Delivery market report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market in the future. Chronic disease prevalence refers to the total number of existing cases of chronic disease in a population at a given time. Pharmaceutical drug delivery helps patients with chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases.

For example, according to the World Health Organization, a Swissspecialized agency of the United Nations, non-communicable diseases kill 41 million people each year, which is equivalent to 71% of all deaths in the world and cardiovascular diseases account for most deaths. Hence, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery market.

The adoption of nano drug delivery systems is a key trend that is gaining popularity in the pharmaceutical drug delivery market. The use of nanomaterials in pharmaceutical drug delivery can increase the cellular uptake of drugs due to surface charge and time and they can increase the stability and water solubility of drugs.

For example, in March 2020Bioavanta-Boston, a SwissThe Chitosan-based Chitosan Nanoparticle Research Organization has released Novochizol, a unique polysaccharide nanotechnology that can be used to encapsulate any effective pharmaceutical additive such as a small molecule or biologic for localized delivery and steady discharge. in any organ or tissue, allowing treatment of COVID-19 infection in the lungs.

In May 2022Halozyme Therapeutics, a US-based biotechnology company, has acquired Antares Pharma for $960 million. With this acquisition, Halozyme aims to strengthen its position as a leader in the distribution of medicines by including Antares specialty products. Antares Pharma is an American company specialized in the distribution of pharmaceutical drugs.

Scope

Covered markets:

1) By route of administration: oral; Ocular; Pulmonary; Nasal; injectables; Topical; Other routes
2) By application: infectious diseases; Cancer; Cardiovascular illnesses; Diabetes; Respiratory diseases; Central nervous system disorders; Autoimmune diseases; Other Apps
3) By end user: Hospitals; Home care settings; CHWs/Clinics; Other end users

Main topics covered:

1. Summary

2. Features of the Pharmaceutical Drug Delivery Market

3. Pharmaceutical Drug Delivery Market Trends and Strategies

4. Impact of COVID-19 on Pharmaceutical Drug Administration

5. Pharmaceutical Drug Delivery Market Size and Growth

6. Pharmaceutical Drug Delivery Market Segmentation

7. Regional and Country Analysis of Pharmaceutical Drug Delivery Market

8. Asia-Pacific Pharmaceutical Drug Delivery Market

9. China Pharmaceutical Drug Delivery Market

10. Indian Pharmaceutical Drug Delivery Market

11. Japan Pharmaceutical Drug Delivery Market

12. Australia Pharmaceutical Drug Delivery Market

13. Indonesia Pharmaceutical Drug Delivery Market

14. South Korea Pharmaceutical Drug Delivery Market

15. Western Europe Pharmaceutical Drug Delivery Market

16. UK Pharmaceutical Drug Delivery Market

17. German pharmaceutical drug delivery market

18. French pharmaceutical drug delivery market

19. Eastern Europe Pharmaceutical Drug Delivery Market

20. Russian pharmaceutical drug delivery market

21. North America Pharmaceutical Drug Delivery Market

22. UNITED STATES Pharmaceutical Drug Delivery Market

23. South America Pharmaceutical Drug Delivery Market

24. Brazil Pharmaceutical Drug Delivery Market

25. Middle East Pharmaceutical Drug Delivery Market

26. Africa Pharmaceutical Drug Delivery Market

27. Pharmaceutical Drug Delivery Market Competitive Landscape and Company Profiles

28. Key Mergers and Acquisitions in the Pharmaceutical Drug Delivery Market

29. Pharmaceutical Drug Delivery Market Future Prospects and Potential Analysis

30. Annex

Companies cited

  • 3M Company
  • Bayer AG
  • Becton Dickinson and company
  • F. Hoffmann-La Roche SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc.
  • Boehringer Ingelheim
  • Boston Scientific Society
  • Bristol-Myers Squibb
  • Consort Medical plc
  • Eli Lilly and company
  • Emergent Biosolutions Inc.
  • Kite Pharma
  • Nemera France SAS
  • Nimbus Therapeutic
  • SHL Medical AG.
  • Teva Pharmaceuticals Industries Ltd.
  • West Pharmaceutical Services Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/dbwzgg

Media Contact:
Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets